Zincas Forte switches from Rx to OTC

…the dispensing status of the medicinal product Zincas Forte (zinci hydroaspartas, 27 mg tablets, ATC code: A12CB), which is used by patients with zinc deficiency. The reclassification took effect on 1 March 2019. The Marketing Authorisation Holder (MAH) is Farmapol Sp. z o.o.

Sign up now to open the entire news item.

You are allowed to open only one news item from PMR websites.
  • 1E-mail
    (to send requested information)
  • 2Brief profile
    (required for new e-mails only)

 required fields

You must accept PMR’s Privacy Policy.